Prevention of anthracycline-induced cardiotoxicity in children: The evidence
- 1 May 2007
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 43 (7), 1134-1140
- https://doi.org/10.1016/j.ejca.2007.01.040
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up studyEuropean Journal Of Cancer, 2006
- Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategiesBritish Journal of Haematology, 2005
- Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2005
- Late anthracycline cardiotoxicity after childhood cancerCancer, 2003
- Childhood cancer survival in Europe and the United StatesCancer, 2002
- Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic reviewAnnals of Oncology, 2002
- Late Mortality Experience in Five-Year Survivors of Childhood and Adolescent Cancer: The Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2001
- Congestive Heart Failure After Treatment for Wilms’ Tumor: A Report From the National Wilms’ Tumor Study GroupJournal of Clinical Oncology, 2001
- Anthracycline-Induced CardiotoxicityAnnals of Internal Medicine, 1996
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979